Physician profile
Robbie Jean Wright
NPI 1982881488
$3,011.91
in general payments reported to CMS, 2019-2025
15 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,827 · 2020: $169 · 2021: $161 · 2022: $207 · 2023: $260 · 2024: $168 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $833.79 | 2019-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $561.97 | 2019-2024 | Jornay Pm |
| Corium, LLC | $319.10 | 2022-2025 | Azstarys |
| Tris Pharma INC | $313.83 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $185.77 | 2019-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $177.53 | 2019 | |
| Shire North American Group INC | $135.05 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $131.22 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Allergan, INC. | $83.90 | 2019-2020 | |
| Lundbeck LLC | $73.94 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $56.63 | 2023-2024 | Caplyta |
| Abbvie INC. | $45.61 | 2025 | |
| Vertical Pharmaceuticals, LLC | $39.57 | 2025 | Relexxii |
| Neos Therapeutics, Lp | $38.30 | 2019-2023 | Adzenys Xr-Odt |
| Collegium Pharmaceutical, INC. | $15.70 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robbie Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.